Evaluation of the Efficacy of E2R Hypnotherapy in the Management of Chronic Insomnia in Primary Care (HypERR)

NANot yet recruitingINTERVENTIONAL
Enrollment

136

Participants

Timeline

Start Date

September 15, 2025

Primary Completion Date

March 15, 2027

Study Completion Date

March 15, 2027

Conditions
Chronic Insomnia
Interventions
OTHER

"Standard care control group (without hypnosis)"

"Randomization stratification on insomnia severity. In the Standard care group, the investigating physician will not change his or her current practice as part of the study. Treatment will be the same as usual, whether drug-based or not (psychotherapy, etc.), with the exception of hypnosis. The patients will be reviewed at 3 months and 6 months (+/- 1 week) after randomization (D0). The following study information and questionnaires will be completed according to patients' responses: ISI and PSQI self-questionnaires, Record of psychotropic medications, Record of any non-drug therapies implemented, Events that could modify sleep, Serious adverse events (EvIG) and non-serious adverse events (EvING) of a neuropsychiatric nature that occurred or worsened during the study."

OTHER

"Experimental group: E2R hypnosis"

"Randomization stratification on insomnia severity. For the patients randomized to the Hypnosis E2R arm, patients summoned within 15 days to 3 weeks of inclusion for their first hypnotherapy session with the hypnotherapist. All patients will receive 4 hypnotherapy sessions over 6 weeks using the E2R method.~The patients will be reviewed at 3 months and 6 months (+/- 1 week) after randomization (D0). The following study information and questionnaires will be completed according to patients' responses: ISI and PSQI self-questionnaires, Record of psychotropic medications, Record of any non-drug therapies implemented, Practice of self-hypnosis requested of the patient (patient diary), Events that could modify sleep, Serious adverse events (EvIG) and non-serious adverse events (EvING) of a neuropsychiatric nature that occurred or worsened during the study."

Trial Locations (33)

Unknown

Cabinet médical, Bain-de-Bretagne

Cabinet médical de Plaisance, Bouaye

Cabinet médical de Plaisance, Bouaye

Cabinet médical de Breteil, Breteil

Cabinet médical, Cesson-Sévigné

Cabinet médical du Linon, Combourg

Cabinet médical Sycamore, Contres

Cabinet médical de Corps Nuds, Corps-Nuds

Cabinet médical des Embruns, Crac'h

Pôle Santé Physiomast, Dol-de-Bretagne

Maison médicale, Iffendic

Cabinet Médical Chantepie, Joué Les Tours

Cabinet Médical de Jugon-Les-Lacs -Saint-Igneuc, Jugon-les-Lacs

Maison médicale des Longrais, La Chapelle-des-Fougeretz

Cabinet médical, La Chapelle-Saint-Ursin

Cabinet médical du Lion d'Or, Nantes

Maison médicale Laennec, Pleudihen-sur-Rance

Maison De Santé De Ronsouze, Ploërmel

Cabinet médical Les Petits Ponts, Pont-Saint-Martin

Cabinet médical Les Petits Ponts, Pont-Saint-Martin

Maison de Santé de Questembert, Questembert

Cabinet médical Olec, Rennes

Cabinet médical, Rennes

Maison médical de Maen roch, Saint-Brice-en-Coglès

Maison médicale, Saint-Gilles-Croix-de-Vie

Maison médicale, Saint-Gilles-Croix-de-Vie

Maison de soin du Couesnon, Saint-Ouen-des-Alleux

Cabinet médical, Saint-Romain-sur-Cher

Maison de santé, Sancerre

Cabinet médical de la Blanchisserie, Sully-sur-Loire

Maison de santé, Talensac

Cabinet des médecins généralistes de TIGY, Tigy

Cabinet médical, Vildé-Guingalan

All Listed Sponsors
collaborator

Rennes University

UNKNOWN

lead

Rennes University Hospital

OTHER